FDA OK of GSK's Promacta Triggers Windfall for Ligand Nov. 24, 2008 By Catherine Hollingsworth No Comments
Infinity to Get $75M Investment, $50M Credit Line from Purdue Nov. 21, 2008 By Catherine Hollingsworth No Comments
XTL Shares Nearly Wiped Out After Failed Nerve Pain Study Nov. 19, 2008 By Catherine Hollingsworth No Comments XTL Biopharmaceuticals Ltd. said that a Phase II study of its bicifadine for the treatment of diabetic nerve pain did not meet any of its objectives, causing the company's shares to fall 94.4 percent. (BioWorld Today)Read More
SciClone Seeks Partner as FDA OKs Melanoma Study Design Nov. 18, 2008 By Catherine Hollingsworth No Comments
Pfizer Focus on Stem Cells Could Help Some Biotechs Nov. 17, 2008 By Catherine Hollingsworth No Comments
AMAG Shares Double on News of Quicker FDA Review Time Nov. 14, 2008 By Catherine Hollingsworth No Comments
ARYx $21.6M Stock Sale Wins Some Partnering Time Nov. 13, 2008 By Catherine Hollingsworth No Comments
Sangamo Shares Take a 65% Hit as Diabetic Nerve Drug Misses Nov. 12, 2008 By Catherine Hollingsworth No Comments
